Revive Therapeutics Ltd. (RVV.CN)
CAD 0.01
(-50.0%)
CAD 0.01
(-50.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -3.28 Million CAD | 39.29% |
| 2022 | -5.41 Million CAD | 69.45% |
| 2021 | -17.71 Million CAD | 4.21% |
| 2020 | -18.49 Million CAD | -282.04% |
| 2019 | -4.84 Million CAD | -267.74% |
| 2018 | -1.31 Million CAD | 30.58% |
| 2017 | -1.89 Million CAD | -13.18% |
| 2016 | -1.67 Million CAD | 37.89% |
| 2015 | -2.69 Million CAD | -32.81% |
| 2014 | -2.03 Million CAD | -123.62% |
| 2013 | -908.28 Thousand CAD | -369.66% |
| 2012 | -193.39 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q3 | -1.85 Million CAD | -136.59% |
| 2023 Q4 | -233.32 Thousand CAD | 87.43% |
| 2023 Q1 | -383.14 Thousand CAD | -7.93% |
| 2023 Q2 | -784.33 Thousand CAD | -104.71% |
| 2022 Q2 | -1.51 Million CAD | 8.08% |
| 2022 Q1 | -1.64 Million CAD | 41.23% |
| 2022 FY | -5.41 Million CAD | 69.45% |
| 2022 Q4 | -355 Thousand CAD | 81.88% |
| 2022 Q3 | -1.95 Million CAD | -29.5% |
| 2021 FY | -17.71 Million CAD | 4.21% |
| 2021 Q2 | -4.08 Million CAD | 15.9% |
| 2021 Q3 | -6 Million CAD | -47.19% |
| 2021 Q4 | -2.8 Million CAD | 53.37% |
| 2021 Q1 | -4.85 Million CAD | 31.72% |
| 2020 Q2 | -2.62 Million CAD | 34.6% |
| 2020 Q3 | -4.24 Million CAD | -61.87% |
| 2020 Q4 | -7.1 Million CAD | -67.28% |
| 2020 FY | -18.49 Million CAD | -282.04% |
| 2020 Q1 | -4.01 Million CAD | -32.81% |
| 2019 Q3 | -1.62 Million CAD | -365.58% |
| 2019 Q2 | -349.93 Thousand CAD | -16.57% |
| 2019 Q4 | -3.02 Million CAD | -85.5% |
| 2019 Q1 | -300.19 Thousand CAD | 34.98% |
| 2019 FY | -4.84 Million CAD | -267.74% |
| 2018 FY | -1.31 Million CAD | 30.58% |
| 2018 Q4 | -461.66 Thousand CAD | -83.27% |
| 2018 Q3 | -251.9 Thousand CAD | 22.11% |
| 2018 Q2 | -323.42 Thousand CAD | -5.39% |
| 2018 Q1 | -306.88 Thousand CAD | 45.91% |
| 2017 Q3 | -400.96 Thousand CAD | 7.66% |
| 2017 Q4 | -567.33 Thousand CAD | -41.49% |
| 2017 FY | -1.89 Million CAD | -13.18% |
| 2017 Q2 | -434.21 Thousand CAD | 1.76% |
| 2017 Q1 | -441.99 Thousand CAD | 25.61% |
| 2016 Q1 | -357.7 Thousand CAD | 24.66% |
| 2016 FY | -1.67 Million CAD | 37.89% |
| 2016 Q4 | -594.15 Thousand CAD | -31.24% |
| 2016 Q3 | -452.7 Thousand CAD | -67.04% |
| 2016 Q2 | -271.01 Thousand CAD | 24.24% |
| 2015 Q3 | -496.65 Thousand CAD | 38.83% |
| 2015 Q2 | -811.91 Thousand CAD | 11.05% |
| 2015 FY | -2.69 Million CAD | -32.81% |
| 2015 Q1 | -912.79 Thousand CAD | -53.11% |
| 2015 Q4 | -474.78 Thousand CAD | 4.4% |
| 2014 Q4 | -596.16 Thousand CAD | -3.57% |
| 2014 Q3 | -575.64 Thousand CAD | -24.95% |
| 2014 Q2 | -460.7 Thousand CAD | -15.58% |
| 2014 Q1 | -398.58 Thousand CAD | 50.77% |
| 2014 FY | -2.03 Million CAD | -123.62% |
| 2013 Q2 | -211.49 Thousand CAD | -154.41% |
| 2013 Q3 | -278.87 Thousand CAD | -31.86% |
| 2013 Q4 | -809.61 Thousand CAD | -190.32% |
| 2013 Q1 | -83.13 Thousand CAD | -2510.11% |
| 2013 FY | -908.28 Thousand CAD | -369.66% |
| 2012 Q2 | -62.13 CAD | -742.77% |
| 2012 Q1 | -7.37 CAD | 0.0% |
| 2012 FY | -193.39 Thousand CAD | 0.0% |
| 2012 Q3 | -29.16 Thousand CAD | -46841.04% |
| 2012 Q4 | -3185.00 CAD | 89.08% |
| 2011 Q4 | - CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aion Therapeutic Inc. | -1.19 Million CAD | -175.918% |
| Ayurcann Holdings Corp. | -3.25 Million CAD | -1.082% |
| Blueberries Medical Corp. | -1.22 Million CAD | -167.905% |
| The BC Bud Corporation | -1.22 Million CAD | -168.582% |
| BioNxt Solutions Inc. | -6.36 Million CAD | 48.392% |
| CordovaCann Corp. | -2.51 Million CAD | -30.785% |
| Christina Lake Cannabis Corp. | -880.54 Thousand CAD | -273.182% |
| Captor Capital Corp. | 655.2 Thousand CAD | 601.526% |
| City View Green Holdings Inc. | -996.45 Thousand CAD | -229.775% |
| 1CM Inc. | 300.79 Thousand CAD | 1192.468% |
| Global Hemp Group Inc. | -551.7 Thousand CAD | -495.613% |
| Greenway Greenhouse Cannabis Corporation | -3.87 Million CAD | 15.288% |
| IM Cannabis Corp. | -12.17 Million CAD | 73.01% |
| Lobe Sciences Ltd. | -3.35 Million CAD | 2.183% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -737.815% |
| Mountain Valley MD Holdings Inc. | -3.18 Million CAD | -3.14% |
| Nextleaf Solutions Ltd. | 542.27 Thousand CAD | 705.979% |
| Ovation Science Inc. | -764 Thousand CAD | -330.106% |
| Pharmadrug Inc. | -1.33 Million CAD | -146.143% |
| Captiva Verde Wellness Corp. | -1.14 Million CAD | -187.751% |
| RAMM Pharma Corp. | -7.08 Million CAD | 53.627% |
| RIV Capital Inc. | 1.78 Million CAD | 284.585% |
| Red White & Bloom Brands Inc. | -8.76 Million CAD | 62.527% |
| SLANG Worldwide Inc. | -5.98 Million CAD | 45.108% |
| 1933 Industries Inc. | -9.34 Million CAD | 64.853% |
| Red Light Holland Corp. | -6.44 Million CAD | 49.025% |
| Top Strike Resources Corp. | -784.8 Thousand CAD | -318.71% |
| Xebra Brands Ltd. | -1.55 Million CAD | -111.384% |
| Adastra Holdings Ltd. | -1.79 Million CAD | -83.193% |